Find a Product

News & Press Releases

Rapidly Develop Drugs Targeting Interleukins with New PathHunter® Cell-Based Assays from DiscoverX

PathHunter® portfolio expansion with Interleukin cell-based assays

DiscoverX Enables Predictive In Vitro Drug Combination Studies with launch of BioMAP® Combo ELECT

Primary Human Cell Models Identify Potential Safe and Efficacious Drug Combinations

DiscoverX Platforms for Phenotypic and Target Based Screening Provide Unique Tools for Cancer Therapeutic Discovery

Primary Human Cell and Co-Culture Assay Systems for Oncology Highly Predictive of Drug Activity in<br /> Relation to Inflammation, Neo-Vascularization and Tumor Microenvironments<br /> <br /> Capabilities for Cancer Drug Discovery Highlighted in &lsquo;Advanced Drug Delivery Reviews&rsquo; Publication<br /> and American Association of Cancer Research 2014 Meeting Presentations<br /> &nbsp;

DiscoverX to Highlight Capabilities of BioMAP® Platform for Investigative Toxicology and Safety Assessment at Society of Toxicology Meeting

Activities Include a Complimentary Workshop on Analysis of Failed Pharmaceutical Compounds Profiled in Primary Human Cell Systems Using BioMAP<sup>&reg;</sup>

Research by Structural Genomics Consortium and DiscoveRx Points to New Multi-Targeting Approaches to Cancer Therapy

Joint Publication Identifies Clinical Kinase Inhibitors that Potently Cross React with Bromodomain Epigenetic Reader Proteins

Displaying results 11-20 (of 42)
 |<  <  1 - 2 - 3 - 4 - 5  >  >|